In contrast, in CC patients with lymphatic metastasis, the amount of CD163+ monocytes (3 subsets were examined) was increased compared to patients without lymphatic metastasis: 87,59 (76,86-99,36) vs. 79,56 (70,72-94,31), p=0,29 (for CD14+CD16-CD163+), 91,48 (86,50-98,05) vs. 77,81 (66,21-94,53), p=0,053 (for CD14+16+163+), and 64,28 (46,67-90,37) vs. 34,18 (4,50-56,29), p=0,061 (for CD14-16+163+) (Figure 2D). The gene discussed is CD163; the disease is Lymphatic Metastasis.